Logo

Genedata, Novartis Expand Lead Discovery Collaboration

May 16, 2006

NEW YORK, May 16 (GenomeWeb News) - Genedata said today that it has expanded a collaboration with the Novartis Institutes for Biomedical Research in the area of high-throughput screening analysis.

 

Under the terms of the expanded collaboration, Novartis will use the Genedata Screener software platform at its sites in Cambridge, Mass., and Basel, Switzerland.

 

The companies began the software collaboration in 2003.

 

Additional terms were not disclosed.

Breaking News
The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.